ADEF
ANIK icon

Adams Diversified Equity Fund’s Anika Therapeutics ANIK Stock Holding History

Adams Diversified Equity Fund’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,000
Closed -$483K – 212
2016
Q3 		$483K Hold
9,000
– – 0.03% 89
2016
Q2 		$483K Buy
+9,000
New +$424K 0.03% 89

Other funds holding ANIK

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adams Diversified Equity Fund's ANIK Position: Q4 2016 in Review

Adams Diversified Equity Fund sold out of Anika Therapeutics (ANIK) in Q4 2016, closing a stake of 9,000 shares — an estimated $483K sold.

Adams Diversified Equity Fund first reported a position in ANIK in Q2 2016 and held it in 2 quarters. The position peaked at $483K in Q3 2016. 158 funds tracked by Wall St. Rank hold ANIK as of Q4 2016.

  • Adams Diversified Equity Fund reported no remaining Anika Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Adams Diversified Equity Fund sold 9,000 Anika Therapeutics shares in Q4 2016, an estimated $483K.
  • Adams Diversified Equity Fund first reported a position in Anika Therapeutics in Q2 2016 and held it in 2 quarters.
  • Adams Diversified Equity Fund's Anika Therapeutics position peaked at $483K in Q3 2016.
  • 158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2016.

Based on Adams Diversified Equity Fund's 13F filing for Q4 2016, filed 14 Feb 2017.